Search results for: 'drug eluting b'

11 Mar 2020  |  North America  |  Market Outlook

Global Homes and Buildings (H&B) Industry Outlook, 2020

Artificial Intelligence (AI)-driven Solutions, Energy Efficiency Directives, Sustainability Targets, Construction Activities, and Stringent Building Safety Codes Drive Overall Industry Growth

Infographics

×

Key Issues Addressed

The homes and buildings (H&B) industry is driven by the penetration of IoT at the field level of buildings, by the emerging adoption of artificial intelligence (AI)-driven solutions at the management level, and by cloud-based data analytics. These technologies are significantly impacting the smart homes, LED lighting, building automation, and build...

Pharmaceutical drug discovery and development suffers from declining success rates with new molecules and the rate of return shrinking from 16Percentage in 2011 to almost 11Percentage in 2018. Frost & Sullivan research indicates that traditional solutions that have focused primarily on data from limited sources and rule-based computational techniqu...

The homes and buildings industry’s future is technology enabled. Recovery from the COVID-19 pandemic combined with decarbonization challenges will accelerate the use of digital building technologies. Heightened awareness about a safe and healthy environment will prompt the use of the internet of things (IoT), artificial intelligence (AI) applicatio...

The growth trajectory of the global life sciences industry has benefited from a combination of novel technologies such as CRISPR-Cas9, microbiome and single-cell, relaxation of entry barriers in markets like China, and better-defined regulatory frameworks around next-generation therapies and companion diagnostics. A common denominator of growth a...

20 Feb 2020  |  Europe  |  Market Outlook

EU Healthcare Predictions and Outlook, 2020

Rise in Orphan Drug R&D Pipeline, AI-based Funding, and Growth in Biocontract Manufacturing to be Key Drivers of Growth

Infographics

×

Amid rising global trade tensions and sluggish global economic outlook for 2020, the global healthcare market is expected to cross the 2-trillion-dollar mark in 2020. In Europe, BREXIT is likely to have a strong impact on the United Kingdom, Europe's biggest digital health market. 2020 will be a global reality check for long-pending national health...

19 Apr 2021  |  North America  |  Market Outlook

Digital and Outcome-linked Service Innovations to Power the Global Homes and Buildings Industry, Outlook 2021

Future Growth Potential Driven by Resilient and Sustainable Business Models

Infographics

×

Key Issues Addressed

The COVID-19 pandemic has impacted nearly every sector and has forced various industries to undergo business transformation initiatives to adapt to the new normal environment. The Homes and Buildings (H&B) industry is no exception and is expected to face an acute recovery challenge both from the supply and demand side of the industry in 2021. As ho...

Biomarker Analytics has always been one of the most in-demand branches of science relevant to the process of drug discovery and development in the Pharmaceutical Industry. Over the years several advances have been made in the area of biomarker analytics with the aim to accelerate the drug development process. The use of AI-based technology can incr...

Pharmaceutical drug discovery and development processes suffer from declining success rates and a stagnant pipeline. Artificial Intelligence (AI) supported by Big Data could be a key element that can provide an effectual solution. There has been a rapid growth in the data generated within the life sciences and pharmaceutical industries. This stems ...

Virtual reality (VR) is an interactive three-dimensional (3D) environment that is computer generated. Immersion into VR is an individual’s perception of having a physical presence in the non-physical world or the virtual world. Technology advancement in in VR in the recent years has led to significant improvements in quality, reductions in overall ...